Literature DB >> 32807690

Benralizumab as initial treatment for chronic eosinophilic pneumonia.

Shusuke Yazawa1, Mikio Toyoshima2, Keigo Koda1, Takafumi Suda3.   

Abstract

Entities:  

Year:  2020        PMID： 32807690     DOI： 10.1016/j.alit.2020.07.005

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  2 in total

1.  Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report.

Authors:  Shimon Izhakian; Barak Pertzov; Dror Rosengarten; Mordechai R Kramer
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 2.  Lessons learned from targeting eosinophils in human disease.

Authors:  Fei Li Kuang; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-04-23       Impact factor: 11.759
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.